Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 1

Status

Completed 3Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 580Neoplasms 487Prostatic Neoplasms 311Lung Neoplasms 238Colorectal Neoplasms 201Motor Activity 131Carcinoma, Non-Small-Cell Lung 117Uterine Cervical Neoplasms 112Brain Neoplasms 110Pancreatic Neoplasms 108Head and Neck Neoplasms 106Stomach Neoplasms 99Carcinoma, Hepatocellular 99Rectal Neoplasms 97Ovarian Neoplasms 86Colonic Neoplasms 86Neoplasm Metastasis 67Multiple Myeloma 65Esophageal Neoplasms 65Hematologic Neoplasms 61Urinary Bladder Neoplasms 60Glioblastoma 59Melanoma 58Sarcoma 57Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Endometrial Neoplasms 56Glioma 53Lymphoma 50Leukemia, Myeloid, Acute 48Gastrointestinal Neoplasms 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Lupus Erythematosus, Systemic × Clear all
NCT07470151 2026-03-13

Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase NA Recruiting
12 enrolled

Autoimmune Diseases, Lupus Erythematosus, Systemic, Myasthenia Gravis, Scleroderma, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡